Stocktoria
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. CELZ
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2009-05-01
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. statistics & valuation
Market cap$4.4M
P / B0.6×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 63.4% | 60.0% | 60.0% | 67.8% | 45.4% |
| Operating margin | -102380.2% | -52216.9% | -62445.9% | -11562.5% | -3562.2% |
| Net margin | -99916.8% | -49940.7% | -58739.7% | -11449.3% | 21892.8% |
| Return on assets | -76.8% | -82.4% | -49.3% | -52.9% | 170.5% |
| Return on equity | -79.7% | -86.6% | -51.1% | -63.9% | 188.0% |
| Current ratio | 25.97 | 18.73 | 27.65 | 5.64 | 10.22 |
| Revenue growth | -45.5% | 22.2% | -89.8% | 1.0% | -46.7% |
Source: SEC EDGAR filings · CIK 0001187953 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.